| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |